Analysis of the structure of chemically synthesized HIV-1 protease complexed with a hexapeptide inhibitor. Part I: Crystallographic refinement of 2 Å data

Proteins: Structure, Function and Genetics

Volumn 27, Issue 2, 1997, Pages 184-195

  Miller, Maria ^a   Geller, Maciej ^a,b   Gribskov, Michael ^a,d   Kent, Stephen B H ^c  

^a NATIONAL CANCER INSTITUTE   (United States)

^b UNIVERSITY OF WARSAW   (Poland)

^c SCRIPPS RESEARCH INSTITUTE   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

aspartic protease; complex with inhibitor; HIV 1

Indexed keywords

PROTEINASE INHIBITOR;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANTIVIRAL ACTIVITY; ARTICLE; DRUG MECHANISM; DRUG PROTEIN BINDING; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; NONHUMAN; PRIORITY JOURNAL; VIRUS REPLICATION;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 0031042237     PISSN: 08873585     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0134(199702)27:2<184::AID-PROT4>3.0.CO;2-G     Document Type: Article

References (39)

1. Miller, M., Jaskólski, M., Mohana, R., Leis, J., Wlodawer, A. Crystal structure of a retroviral protease proves relationship to aspartic protease family. Nature 337:576-579, 1989.
2. Navia, M.A., Fitzgerald, P.M.D., McKeever, B.M., Leu, C.-T., Heimbach, J.C., Herber, W.K., Sigal, I.S., Darke, P.L., Springer, J.P. Three-dimensional structure of aspartyl protease from human immunodeficiency virus HIV-1. Nature 337:615-620, 1989.
3. Jaskólski, M., Miller, M., Mohana, Rao, J.K., Leis, J., Wlodawer, A. Structure of the aspartic protease from Rous sarcoma retrovirus refined at 2 Å resolution. Biochemistry 29:5889-5898, 1990.
4. Wlodawer, A., Miller, M., Jaskólski, M., Sathyanarayana, B.K., Baldwin, E., Weber, I.T., Selk, L.M., Clawson, L., Schneider, J., Kent, S.B.H. Conserved folding in retroviral proteases: Crystal structure of a synthetic HIV-1 protease. Science 245:616-621, 1989.
5. Lapatto, R., Blundell, T., Hemmings, A., Overington, J., Wilderspin, A., Wood, S., Merson, J.R., Whittle, P.J., Danley, D.E., Geoghegan, K.F., Hawrylik, S.J., Lee, S.E., Scheld, K.G., Hobart, P.M. X-ray analysis of HIV-1 proteinase at 2.7 Å resolution confirms structural homology among retroviral enzymes. Nature 342:299-302, 1989.
6. Kostka, V. "Aspartic Proteinases and Their Inhibitors." Berlin: de Gruyter, 1985.
7. Davies, D.R. The structure and function of the aspartic proteinases. Annu. Rev. Biophys. Biophys. Chem. 19:189-215, 1990.
8. Richards, A.D., Roberts, R., Dunn, B.M., Graves, M.C., Kay, J. Effective blocking of HIV-1 protease activity by characteristic inhibitions of aspartic proteinases. FEBS Lett. 247:113-117, 1989.
9. Schneider, J., Kent, S.B.H. Enzymatic activity of a synthetic 99 residue protein corresponding to the putative HIV-1 protease. Cell 54:363-368, 1989.
10. Miller, M., Schneider, J., Sathyanarayana, B.K., Toth, M.V., Marshall, G.R., Clawson, L., Selk, L., Kent, S.B.H., Wlodawer, A. Structure of complex of synthetic HIV-1 protease with a substrate-based inhibitor at 2.3 Å resolution. Science 246:1149-1152, 1989.
11. DesJarlais, R.L., Seibel, G.L., Kuntz, I.D., Furth, P.S., Alvarez, J.C., Ortiz de Montellano, P.R., DeCamp, D.L., Babé, L.M., Craik, C.S. Structure-based design of nonpeptide inhibitors specific for the human immunodeficiency virus 1 protease. Proc. Natl. Acad. Sci. USA 87:6644-6648, 1990.
12. Caflisch, A., Miranker, A., Karplus, M. Multiple copy simultaneous search and construction of ligands in binding sites: Application to inhibitors of HIV-1 aspartic proteinase. J. Med. Chem. 36:2142-2167, 1993.
13. Gustchina, A., Weber, I.T. Comparative analysis of the sequences and structures of HIV-1 and HIV-2 proteases. Proteins 10:325-339, 1991.
14. Swain, A.L., Miller, M., Green, J., Rich, D.H., Kent, S.B.H., Wlodawer, A. X-ray crystallographic structure of a complex between HIV-1 protease and hydroxyethylamine inhibitor. Proc. Natl. Acad. Sci. USA 87:8805-8809, 1990.
15. Jaskólski, M., Tomasselli, A.G., Sawyer, T.K., Staples, D.G., Heinrikson, R.L., Schneider, J., Kent, S.B.H., Wlodawer, A. Structure at 2.5-Å resolution of chemically synthesized human immunodeficiency virus type 1 protease complexed with a hydroxyethylene-based inhibitor. Biochemistry 30:1600-1609, 1991.
16. Thanki, N., Mohana Rao, J.K., Foundling, S.I., Howe, W.J., Moon, J.B., Hui, J.O., Tomasselli, A.G., Heinrikson, R.L., Thaisrivongs, S., Wlodawer, A. Crystal structure of a complex of HIV-1 protease with dihydroksyethylene-containing inhibitor: Comparison with molecular modeling. Prot. Sci. 1:1061-1072, 1992.
17. York, D.M., Darden, T.A., Pedersen, L.G., Anderson, M.W. Molecular dynamics simulation of HIV-1 protease in a crystalline environment and in solution. Biochemistry 32:1443-1453, 1993.
18. Sansom, C.E., Wu, J., Weber, I.T. Molecular mechanics analysis of inhibitor binding to HIV-1 protease. Prot. Eng. 5:659-667, 1992.
19. Fitzgerald, P.M.D. HIV protease-ligand complexes. Curr. Opin. Struct. Biol. 3:868-874, 1993.
20. Appelt, K. Crystal structures of HIV-1 protease-inhibitor complexes. Perspect. Drug Discovery Design 1:23-47, 1993.
21. Wlodawer, A., Erickson, J.W. Structure-based inhibitors of HIV-1 protease. Annu. Rev. Biochem., 62:543-585, 1993.
22. Roberts, N.A., Martin, J.A., Kinchington, D., Broadhurst, A.V., Craig, J.C., Duncan, I.E., Galpin, S.A., Handa, B.K., Kay, J., Kröhn, A., Lambert, R.W., Merrett, J.H., Mills, J.S., Parkes, K.E.B., Redshaw, S., Ritchie, A.J., Taylor, D.L., Thomas, G.J., Machin, P.J. Rational design of peptide-based HIV proteinase inhibitors. Science 248:358-361, 1990.
23. Vacca, J.P., Dorsey, B.D., Schleif, W.A., Levin, R.B., McDaniel, S.L., Darke, P.L., Zugay, J., Quintero, J.C., Blahy, O.M., Roth, E., Sardana, V.V., Schlabach, A.J., Graham, P.I., Condra, J.H., Gotlib, L., Holloway, M.K., Lin, J., Chen, I.-W., Vastag, K., Ostovic, D., Anderson, P.S., Emini, E.A., Huff, J.R. L-735,524: An orally bioavailable human immunodeficiency virus type 1 protease inhibitor. Proc. Natl. Acad. Sci. USA 91:4096-4100, 1994.
24. Kempf, D.J., Marsh, K.C., Denissen, J.F., McDonald, E., Vasavanonda, S., Flentge, C.A., Green, B.E., Fino, L., Park, C.H., Kong, X.-P., Wideburg, N.E., Saldivar, A., Ruiz, L., Kati, W.M., Sham, H.L., Robins, T., Stewart, K.D., Hsu, A., Plattner, J.J., Leonard, J.M., Norbeck, D.W. ABT-538 is a potent inhibitor of human immunodeficiency virus protease and has high oral bioavailability in humans. Proc. Natl. Acad. Sci. USA 92:2484-2488, 1995.
25. Erickson, J., Neidhart, D.J., VanDrie, J., Kempf, D.J., Wang, X.C., Norbeck, D.W., Plattner, J.J., Rittenhouse, J.W., Turon, M., Wideburg, N., Kohlbrenner, W.E., Simmer, R., Helfrich, R., Poul, D.A., Knigge, M. Design, activity, and 2.8 Å crystal structure of C2 symmetric inhibitor complexed to HIV-1 protease. Science 249:527-533, 1990.
26. Fitzgerald, P.M., McKeever, B.M., VanMiddlesworth, J.F., Springer, J.P., Heimbach, J.C., Chih-Tai Leu, Herbert, W.K., Dixon, R.A.F., Darke, P.L. Crystallographic analysis of a complex between human immunodeficiency virus type 1 protease and acetyl-pepstatin at 2.0-Å resolution. J. Biol. Chem., 265:14209-14219, 1990.
27. Toth, M.V., Chiu, F., Glover, G., Kent, S.B.H., Ratner, L., Van der Heyden, N., Green, J., Rich, D.H., Marshall, G.R. In: "Proceedings of the Eleventh American Peptide Symposium." Rivier, J., Marshall, G.R. (eds.). Ae Leiden, The Netherlands: Escom Science Publishers, 1990:835.
28. Howard, A.J., Gilliland, G.L., Finzel, B.C., Poulos, T.L., Ohlendord, D.H., Salemme, F.R. The use of an imaging proportional counter in macromolecular crystallography. J. Appl. Crystallogr. 20:383-387, 1987.
29. Hendrickson, W. Stereochemically restrained refinement of macromolecular structures. Methods Enzymol. 252-270, 1985.
30. Finzel, B.C. Incorporation of fast Fourier transforms to speed least squares refinement of protein structures. J. Appl. Crystallogr. 20:53-55, 1987.
31. Jones, T.A. A graphics model building and refinement system for macromolecules. J. Appl. Crystallogr. 11:268-272, 1978.
32. Brünger, A.T., Kuriyan, J., Karplus, M. Crystallographic R factor refinement by molecular dynamics. Science 235:458-460, 1987.
33. Satow, Y., Cohen, G.H., Padlan, E.A., Davies, D.R. Phosphocholine binding immunoglobulin Fab Mc PC603: An x-ray diffraction study at 2.7 Å J. Mol. Biol. 190:593-604, 1986.
34. Weber, I.T. Comparison of the crystal structures and intersubunits interactions of human immunodeficiency and Rous Sarcoma virus proteases. J. Biol. Chem. 265: 10492-10496, 1990.
35. 1 phenyl substituents: X-ray crystal structure assisted design. J. Med. Chem. 35:1685-1701, 1992.
36. Dreyer, G.B., Lambert, D.M., Meek, T.D., Carr, T.J., Tomaszek, Jr., T.A., Fernandez, A.V., Bartus, H., Cacciavillani, E., Hassell, A.M., Minnich, M., Peteway, Jr., S.R., Metcalf, B.W. and Lewis, M. Hydroxyethylene isostere inhibitors of human immunodeficiency virus-1 protease: Structure-activity analysis using enzyme kinetics, x-ray crystallography, and infected T-cell assays. Biochemistry 31:6646-6659, 1992.
37. Hodel, A., Kim, S-H., and Brünger, A.T., Model bias in macromolecular crystal structures. Acta Crystallogr. A48: 851-858, 1992.
38. Suguna, K., Padlan, E.A., Smith, C.W., Carlson, W.D., Davies, D.R. Binding of a reduced peptide inhibitor to the aspartic proteinase from Rhizopus chinensis: Implications for a mechanism of action. Proc. Natl. Acad. Sci. USA 84:7009-7013, 1987.
39. Meyer, E. Internal water molecules and H-bonding in biological macromolecules: A review of structural features with functional implications. Prot. Sci. 1:1543-1562, 1992.